Reaction: Osimertinib to 1 product

Reaction
Osimertinib
DB09330
AZ-7550
DBMET03777
Reaction type
demethylation
Direction
Major circulating metabolite?
Yes
Spontaneous?
No
Activity
active
References
  1. FDA Approved Drug Products: TAGRISSO (osimertinib) tablets, for oral use (February 2024) [Link]
Comments
Not Available
Enzymes
EnzymeKmVmaxRole
Cytochrome P450 3A SubfamilyNot AvailableNot Availableconfirmed